Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts (SEG-PROM)

April 13, 2026 updated by: Murat Çelik, Cumhuriyet University Hospital

Patient-Reported Outcomes and Complications Following Structural Rhinoplasty Using Septal Extension Grafts: A Prospective Cohort Study

Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective.

Patient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited.

This prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoperative follow-up visits at approximately 1, 3, and 6 months.

In addition, postoperative complications and revision procedures will be recorded. The study aims to provide a more comprehensive understanding of patient-centered outcomes and their relationship with clinical findings in SEG-based rhinoplasty.

Study Overview

Status

Recruiting

Detailed Description

Structural rhinoplasty is performed to achieve stable and lasting aesthetic and functional outcomes by rebuilding and maintaining the nasal framework. Among nasal tip support techniques, the septal extension graft (SEG) is widely used due to its ability to provide reliable control of nasal tip projection and rotation while maintaining structural stability.

Surgical success in rhinoplasty is not limited to anatomical outcomes alone. Patient perception of nasal function and appearance plays a key role in overall satisfaction. Therefore, patient-reported outcome measures (PROMs) have become an important component in outcome assessment.

Despite the widespread use of SEG, prospective data evaluating longitudinal changes in PROMs together with postoperative clinical findings remain limited. Clinical factors such as tip stiffness, palpable grafts, columellar deviation, and the need for revision surgery may influence patient-reported outcomes, but their relationship with PROM score changes over time has not been clearly defined.

This study is designed as a single-center, prospective observational cohort including consecutive adult patients undergoing primary structural rhinoplasty with SEG-based tip support. All procedures will be performed by the same surgical team using a standardized structural approach, with additional techniques applied as required based on individual anatomical characteristics.

Patient-reported outcomes will be assessed using validated instruments, including the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS), the Rhinoplasty Outcome Evaluation (ROE), and the Nasal Obstruction Symptom Evaluation (NOSE) scale. Assessments will be performed preoperatively and at postoperative follow-up visits.

Follow-up evaluations are planned at approximately 1, 3, and 6 months. Early postoperative assessments may be influenced by edema; therefore, later time points will be considered more representative of stable outcomes.

Data will be collected prospectively using standardized case report forms with predefined variables. PROM data will be obtained through patient-completed questionnaires at each visit. Clinical findings, including postoperative status and complications, will be recorded during routine follow-up examinations. Data entry will be performed contemporaneously at each visit.

Postoperative complications will be recorded and categorized according to timing. Revision procedures occurring during the follow-up period will also be documented. The study is structured to allow evaluation of longitudinal changes in PROM scores and to explore potential associations between patient-reported outcomes and clinical findings.

Consecutive patient inclusion will be used to reduce selection bias. Data quality will be supported by predefined variable definitions, consistency checks, and periodic data review. Missing data will be documented and handled using appropriate statistical methods for repeated measures analyses.

This study aims to characterize longitudinal changes in PROM scores and their relationship with postoperative clinical findings in patients undergoing SEG-based structural rhinoplasty.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Murat Çelik, Assistant Professor
  • Phone Number: +905546902104
  • Email: mucetr@gmail.com

Study Contact Backup

Study Locations

    • Sivas
      • Sivas, Sivas, Turkey (Türkiye), 58070
        • Recruiting
        • Sivas Cumhuriyet University
        • Contact:
        • Contact:
          • Murat Çelik, Assistant Professor
          • Phone Number: 05546902104
        • Principal Investigator:
          • Handan Derebaşınlıoğlu, Associate Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients undergoing primary structural rhinoplasty with septal extension graft at a tertiary referral center. Patients are consecutively enrolled and followed prospectively.

Description

Inclusion Criteria:

  • Age 18 years or older
  • Undergoing primary structural rhinoplasty with septal extension graft
  • Able to understand and complete patient-reported outcome questionnaires (PROMs)
  • Willing to participate and provide written informed consent

Exclusion Criteria:

  • History of previous nasal surgery (revision rhinoplasty)
  • Undergoing concomitant major craniofacial procedures
  • Missing preoperative PROM data
  • Unable to complete postoperative follow-up assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Structural Rhinoplasty with Septal Extension Graft
Adult patients undergoing primary structural rhinoplasty with septal extension graft (SEG)-based nasal tip support. All patients are treated using a standardized surgical approach by the same surgical team, with additional techniques applied as needed according to individual anatomy. Patients are followed prospectively and evaluated using patient-reported outcome measures and clinical outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 6
Time Frame: Baseline to postoperative month 6
Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 6. The SCHNOS score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes. Postoperative month 6 represents a time point at which most postoperative edema has subsided and nasal structures are relatively stable.
Baseline to postoperative month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 6
Time Frame: Baseline to postoperative month 6
Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 6. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes
Baseline to postoperative month 6
Change from Baseline in Nasal Obstruction Symptom Evaluation (NOSE) Score at Postoperative Month 6
Time Frame: Baseline to postoperative month 6
Change in the score of the Nasal Obstruction Symptom Evaluation (NOSE) scale from preoperative baseline to postoperative month 6. The NOSE score ranges from 0 to 100, with higher scores indicating more severe nasal obstruction symptoms.
Baseline to postoperative month 6
Revision Surgery Rate Within 6 Months
Time Frame: Up to postoperative month 6
Proportion of patients requiring revision surgery within 6 months following the primary rhinoplasty procedure.
Up to postoperative month 6

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 1
Time Frame: Baseline to postoperative month 1
Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 1. The SCHNOS total score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes.
Baseline to postoperative month 1
Change from Baseline in Total Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) Score at Postoperative Month 3
Time Frame: Baseline to postoperative month 3
Change in the total score of the Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) from preoperative baseline to postoperative month 3. The SCHNOS total score ranges from 0 to 100, with higher scores indicating worse nasal symptoms and poorer aesthetic outcomes.
Baseline to postoperative month 3
Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 1
Time Frame: Baseline to postoperative month 1
Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 1. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes.
Baseline to postoperative month 1
Change from Baseline in Rhinoplasty Outcome Evaluation (ROE) Score at Postoperative Month 3
Time Frame: Baseline to postoperative month 3
Change in the score of the Rhinoplasty Outcome Evaluation (ROE) from preoperative baseline to postoperative month 3. The ROE score ranges from 0 to 100, with higher scores indicating better patient satisfaction and improved outcomes.
Baseline to postoperative month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Murat Çelik, Assistant Professor, Cumhuriyet University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 24, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

April 1, 2026

First Submitted That Met QC Criteria

April 13, 2026

First Posted (Actual)

April 15, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nasal Obstruction

Subscribe